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AbsTrACT
Objective To determine the feasibility of Fluids in Shock, 
a randomised controlled trial (RCT) of restricted fluid bolus 
volume (10 mL/kg) versus recommended practice (20 mL/kg).
Design Nine-month pilot RCT with embedded mixed-
method perspectives study.
setting 13 hospitals in England.
Patients Children presenting to emergency departments 
with suspected infection and shock after 20 mL/kg fluid.
Interventions Patients were randomly allocated (1:1) to 
further 10 or 20 mL/kg fluid boluses every 15 min for up to 
4 hours if still in shock.
Main outcome measures These were based on 
progression criteria, including recruitment and retention, 
protocol adherence, separation, potential trial outcome 
measures, and parent and staff perspectives.
results Seventy-five participants were randomised; two 
were withdrawn. 23 (59%) of 39 in the 10 mL/kg arm and 
25 (74%) of 34 in the 20 mL/kg arm required a single trial 
bolus before the shock resolved. 79% of boluses were 
delivered per protocol in the 10 mL/kg arm and 55% in 
the 20 mL/kg arm. The volume of study bolus fluid after 
4 hours was 44% lower in the 10 mL/kg group (mean 14.5 
vs 27.5 mL/kg). The Paediatric Index of Mortality-2 score 
was 2.1 (IQR 1.6–2.7) in the 10 mL/kg group and 2.0 (IQR 
1.6–2.5) in the 20 mL/kg group. There were no deaths. 
Length of hospital stay, paediatric intensive care unit (PICU) 
admissions and PICU-free days at 30 days did not differ 
significantly between the groups. In the perspectives study, 
the trial was generally supported, although some problems 
with protocol adherence were described.
Conclusions Participants were not as unwell as expected. 
A larger trial is not feasible in its current design in the UK.
Trial registration number ISRCTN 15244462.
bACkgrOunD
Rapid, bolus fluid resuscitation is integral to the 
management of children presenting with septic 
shock. The 2009 American College of Critical 
Care Medicine-Pediatric Advanced Life Support 
(ACCM-PALS) clinical guideline recommended 
fluid resuscitation with boluses of 20 mL/kg, up to 
a total of 200 mL/kg in the first hour.1 However, 
this recommendation is now controversial; it was 
based on retrospective observational studies, some 
involving small numbers of children,2–4 and audit 
data have shown that the recommendations are 
often not followed.5 
In Africa, a multicentre randomised controlled 
trial (RCT), the Fluid Expansion as Supportive 
Therapy (FEAST) trial, compared bolus fluid 
resuscitation of 20 mL/kg with maintenance fluid 
in over 3000 children with severe infection.6 The 
study reported 35% higher mortality associated 
with bolus fluid resuscitation. Although conducted 
in Africa in a low-income setting, the FEAST trial 
highlighted the lack of evidence for bolus fluid 
resuscitation for children in middle-income and 
high-income settings.7 8
No trial has compared restricted bolus fluid 
resuscitation strategy with recommended bolus 
fluid resuscitation in children with septic shock 
in high-income countries. In the UK, children 
presenting to emergency departments (EDs) with 
severe sepsis and discussed with a paediatric inten-
sive care retrieval service have a reported mortality 
of up to 17%.9 With emerging data suggesting 
that excessive fluid administration is associated 
with worse outcomes in paediatric intensive care 
What is already known on this topic?
 ► Rapid, liberal fluid bolus resuscitation is integral 
to the management of children presenting to 
emergency departments with septic shock.
 ► No trials have compared a more restricted 
fluid bolus resuscitation strategy with the 
currently recommended strategy in high-income 
countries.
 ► The optimal amount of fluid for resuscitation for 
children presenting with septic shock in high-
income countries is an important unanswered 
question.
What this study adds?
 ► The Fluids in Shock (FiSh) pilot compared a 
restricted fluid bolus volume (10 mL/kg) with 
the current recommendation (20 mL/kg) to 
determine the feasibility of a large-scale trial.
 ► A larger FiSh trial is not feasible; participants 
had a lower severity of illness than expected.
 ► Further observational work is required to 
determine the epidemiology of severe childhood 
infection in the UK in the postvaccine era.
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unit (PICU),10–14 the optimal amount of fluid for resuscitation 
for children presenting with septic shock remains an important 
unanswered question.
To address this problem, the Fluids in Shock (FiSh) trial was 
developed, which aimed to evaluate whether a restricted fluid 
bolus volume (10 mL/kg), compared with currently recom-
mended fluid bolus volume (20 mL/kg), is associated with 
improved outcomes for children presenting to UK EDs with 
presumed septic shock. Our initial qualitative feasibility study 
results have been reported previously.15 This paper reports the 
results of the external pilot trial and embedded parent and staff 
perspectives study.
MeThODs
study design
The study design was a pragmatic, open, multicentre pilot RCT. 
The pilot trial was sponsored by the Imperial College Health-
care NHS Trust and coordinated by the Intensive Care National 
Audit & Research Centre Clinical Trials Unit (CTU). The 
ISRCTN trial registration number is 15244462. The protocol is 
available at https://www. journalslibrary. nihr. ac. uk/ programmes/ 
hta/ 1304105/#/.
Pilot trial
Sites and participants
Sites were set up in a ‘hub and spoke’ model in three regions 
in England. The ‘hubs’ were four regional hospitals with PICUs 
(two hospitals covered the same region), three of which also 
had an integrated ED. The ‘spokes’ were nine district general 
hospitals with an ED but not a PICU linked to the ‘hub’ PICU 
by the regional PICU retrieval service. Participating EDs were 
research-active sites and part of the Paediatric Emergency 
Research in the United Kingdom & Ireland network.16 Exten-
sive training was provided for the site teams, including a site 
initiation visit from the CTU and local training of clinical staff 
by their own research staff.
The inclusion criteria were age older than 37 weeks (corrected 
gestational age) and younger than 16 years; clinical suspicion of 
infection; and signs of shock—defined as age-adjusted hypotension 
(less than fifth centile systolic blood pressure (BP) for age or capil-
lary refill time (CRT) greater than or equal to 3 s)—after receipt 
of 20 mL/kg of bolus fluid. Fifth centile systolic BP was provided 
to sites in age bands on wallet-sized cards for quick reference 
(<1 week: <60 mm Hg; 1 week to <1 year: <70 mm Hg; 1 to <2 
years: <75 mm Hg; 2 to <5 years: <80 mm Hg; 5 to <12 years: 
<85 mm Hg; and ≥12 years: <90 mm Hg). The exclusion criteria 
were prior receipt of more than 20 mL/kg of bolus fluid; conditions 
in which bolus fluid resuscitation should be curtailed; or full active 
resuscitation not within the current goals of care.
Randomisation and trial intervention
Eligible patients were randomised while in an acute assessment area 
(eg, paediatric assessment unit or ED) and allocated 1:1 to either 
10 mL/kg or 20 mL/kg boluses over a 4-hour resuscitation period, 
without prior consent. The resuscitation period was divided into 
15 min cycles, with one bolus of either 10 mL/kg or 20 mL/kg to be 
delivered in each cycle. The maximum amount of fluid that could 
be given per bolus was either 500 mL (for those allocated to 10 mL/
kg boluses) or 1000 mL (for those allocated to 20 mL/kg boluses). 
Fluid type and other interventions were left to the discretion of 
the treating clinician. At the end of each cycle, if age-adjusted signs 
of shock persisted, then another bolus of the same size was given 
within the next 15 min cycle.
In participants whose shock resolved or who showed signs 
of fluid overload (pulmonary oedema—rales on auscultation 
or pulmonary oedema fluid in the endotracheal tube—or new 
or increasing hepatomegaly), delivery of further fluid boluses 
was withheld. If, within the 4-hour resuscitation period, fluid 
boluses were indicated, that is, signs of shock were present in 
the absence of signs of fluid overload, cycles were recommenced 
with allocated boluses until the end of the 4-hour intervention 
period. After this period, any further treatment was at the discre-
tion of the treating clinician.
The maximum amount of fluid that could be given within 
the pilot trial protocol, regardless of allocation, was 120 mL/kg 
(excluding the 20 mL/kg bolus prerandomisation).
Consent
A member of the site research team approached parents/legal 
representatives as soon as appropriate after randomisation to take 
consent for use of study data, according to the guidance developed 
in the FiSh feasibility study15 and elsewhere.17–21 This is known as 
research without prior consent (RWPC), a methodology favoured 
in emergency care trials.22 23 Specific FiSh RWPC methodology was 
developed during the feasibility study15 for all possible situations, 
including early discharge or death of the participant.
Outcome measures
The objectives of the pilot trial were to test if the processes 
worked together, and to inform the design and conduct of the 
full FiSh trial (should this be the recommendation from the pilot). 
Outcome measures were driven by the progression criteria to be 
assessed by the pilot, and included recruitment and retention, 
protocol adherence and demonstration of separation between 
the groups, distribution of potential trial outcome measures, and 
parent and staff perspectives.
These were determined by the proportion of eligible partic-
ipants recruited, number of participants recruited per site per 
month, proportion of parents/legal representatives refusing 
consent, proportion of fluid boluses delivered at the correct 
volume and time during the intervention period (at least 80% of 
bolus fluid resuscitation delivered at correct volume and timing 
±10%), total volume of fluid received during the intervention 
period in each treatment group (absolute total volume of fluid 
administered during the first hour and first 4 hours is lower (by 
at least 25%) in the 10 mL/kg group), characteristics of potential 
outcome measures and observed adverse events, and parent and 
staff perspectives.
Data collection was via a secure, dedicated, electronic database. 
Sites collected data throughout each patient’s hospital admission on 
the inclusion criteria, baseline—including the Paediatric Index of 
Mortality (PIM2r; the recalibrated version of PIM2 score, a PICU 
severity of illness score giving a population risk of mortality)24 25 
interventions, physiology, location of care to hospital discharge and 
survival at day 30. For participants admitted to PICU, daily organ 
support data were obtained via linkage with the Paediatric Intensive 
Care Audit Network, the UK national clinical audit for paediatric 
intensive care.
Statistical analysis
The trial was set up as a small pilot RCT without a defined 
primary outcome, and hence without a usual power calculation 
to determine sample size. Instead, sample size was determined to 
be adequate to estimate the parameters to be tested.26 Based on 
available data, it was anticipated that the 12 EDs would recruit 
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approximately one participant per month, that is, 108 partici-
pants over 9 months.
All statistical analyses were documented a priori in a Statis-
tical Analysis Plan (available from https://www. icnarc. org/ Our- 
Research/ Studies/ Fish/ Study- Documents). Statistical analyses 
were based on the intention-to-treat principle. All tests used 
were two-sided with significance levels set at p<0.05 and with 
no adjustment for multiplicity. Final analyses were conducted 
using Stata/SE V.14.0.
embedded perspectives study
This was a mixed-method study which aimed to explore parent 
and staff experiences and views of the pilot trial. The participants 
were pilot trial site staff and parents of randomised children. The 
questionnaire and topic guides were developed using previous 
research17 and feasibility study findings.15 Quantitative data were 
collected from the focus groups via a keypad voting system, along-
side audio-recorded qualitative discussions. Informed consent was 
taken. Interviews continued until no new themes were identified, 
that is, data saturation was reached.27 Qualitative data analysis was 
performed according to the methodology outlined in the feasibility 
study.14 Quantitative data were analysed using simple descriptive 
statistics. Data synthesis was pragmatic and drew on the constant 
comparative approach.28 29
resulTs
Pilot trial
Sites, participants and recruitment
The pilot trial was conducted in 13 hospitals from July 2016 
to April 2017, with follow-up completed on 31 May 2017. 
In total, 297 patients who had received a fluid bolus of any 
size were screened. Eighty-eight (29.8%) received a fluid bolus 
of less than 20 mL/kg, while 108 (51.7%) did not meet the 
defined clinical signs of shock after receiving 20 mL/kg. There 
were 18 (17.8%) patients who met one or more exclusion 
criteria.
Overall, 75 (90.4%) out of 83 eligible patients were recruited, 
40 into the 10 mL/kg group and 35 into the 20 mL/kg group. 
Two were withdrawn (figure 1) as the parents/legal representa-
tives could not be approached for informed consent. The overall 
recruitment rate was 0.9 participants per site per month (95% 
CI 0.7 to 1.2), although the majority of recruitment was led by 
three sites. Recruitment was stopped at the end of the prespeci-
fied 9-month period from first site opening.
Baseline characteristics were well matched, although there 
was some imbalance in age and consequently in weight (table 1). 
The majority of participants met the shock criteria of CRT≥3 s 
(76.9% in 10 mL/kg group, 88.2% in 20 mL/kg group). The 
PIM2r score was balanced across treatment groups but was 
lower than expected. The mean PIM2r score was 2.1%.
Thirty-seven participants (51.3% in 10 mL/kg group, 50% 
in 20 mL/kg group) had infection confirmed by the site team, 
that is, positive bacterial, viral or fungal microscopy, culture, 
PCR or immunofluorescence test. However, in five of these, 
the organism was not recorded. Of the remaining 32, 13 had 
bacterial infections in sterile sites (table 1), only one of which 
was vaccine-preventable. There were 18 viral infections, most of 
which were respiratory pathogens. One patient had falciparum 
malaria.
Figure 1 Consolidated Standards of Reporting Trials flow diagram.
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Adherence to protocol and separation
All participants randomised to the 20 mL/kg group received their 
first bolus. Three participants randomised to the 10 mL/kg group 
did not receive their first bolus, although correctly identified as 
in shock, because it was deemed they no longer required fluid 
postrandomisation. Of the subsequent boluses, one participant 
in the 20 mL/kg group was administered a bolus when the shock 
criteria were not met. Five participants in total (three from the 
10 mL/kg group and two from the 20 mL/kg group) who met the 
shock criteria did not receive the designated fluid bolus (table 2).
The majority of participants in both groups received one fluid 
bolus, 23 (59%) in the 10 mL/kg group and 25 (74%) in the 
20 mL/kg group. During the total 4-hour intervention period, 
only four patients received four or more fluid boluses. Seventy 
per cent of participants required only one study fluid bolus and 
only 11% required more than two study boluses.
Assessment of the separation progression criteria showed that 
the mean total volume of study fluid given during the first hour 
was 38% lower (13.5 vs 20.7 mL/kg) and during the entire 4-hour 
intervention period was 44% lower (mean 14.5 vs 27.5 mL/kg) in 
the 10 mL/kg group compared with the 20 mL/kg group. At the end 
of the 4-hour intervention period, this corresponded to a statisti-
cally significant mean difference of −11.2 mL/kg (95% CI –16.6 to 
–5.8 mL/kg; p<0.001). With regard to the adherence progression 
criteria, overall, 37 (78.7%) of 47 boluses were delivered at the 
correct volume and within 15 min in the 10 mL/kg group, whereas 
24 (54.5%) of 44 boluses were delivered at the correct volume and 
within 15 min in the 20 mL/kg group (table 3).
Potential outcome measures for a future trial
There were no deaths and no serious adverse events reported. 
Two patients in the 20 mL/kg group developed signs of fluid 
overload after the first study bolus, and consequently did not 
receive a second bolus despite remaining in shock. Overall, 29% 
participants were admitted to PICU. As expected in this small 
pilot trial, length of hospital stay, transfers to PICU, length of 
stay in PICU and days alive and free of PICU to 30 days did not 
differ significantly between the groups (table 4).
embedded perspectives study
A total of 52 (69%) of 75 parents of randomised participants 
provided consent to complete a questionnaire or take part in a 
telephone interview. Of these, 45 (87%) parents (34 mothers, 
11 fathers) from 44 families completed a questionnaire before 
leaving the hospital. Data saturation was reached at 20 (38%) of 
52 interviews with parents (19 mothers, 1 father; 26.5 (median) 
days since child’s admission). There were three pilot trial ‘hub’ site 
focus groups (20 staff) and telephone interviews with 7 (35%) of 
20 invited staff (until data saturation point), including 14 (52%) of 
27 nurses and 13 (48%) of 27 doctors from 7 (58%) of 12 sites (for 
thematic analysis, see online supplementary file).
Interview and questionnaire data indicated some parents were 
surprised to discover that their child had been enrolled into the 
pilot trial without prior informed consent (online supplementary 
file). However, clear explanations from site staff about RWPC 
and the nature of the intervention appeared to elicit parental 
support.
Site training had prepared staff for recruitment and RWPC. The 
randomisation method was viewed as straightforward. However, 
some clinical staff found it difficult to complete the case report 
form while treating a child. Staff also described problems adhering 
to the protocol, including administering 20 mL/kg boluses within 
the 15 min cycles and a lack of equipoise among a minority of clini-
cians when a child had been randomised to a 20 mL/kg allocation 
due to concerns about fluid overload.
Table 1 Baseline characteristics of patients by treatment group
Characteristics
10 ml/kg
(n=39)
20 ml/kg
(n=34)
Age (months) 
  Median (IQR) 11 (1–35) 2 (1–17)
Gender, n (%) 
  Male 24 (61.5) 18 (52.9)
  Female 15 (38.5) 16 (47.1)
Weight (kg) 
  Median (IQR) 9 (5–13) 5 (4–10)
Shock criteria met, n (%) 
  CRT* only 30 (76.9) 30 (88.2)
  Hypotension only 2 (5.1) 2 (5.9)
  CRT* and hypotension 1 (2.6) 2 (5.9)
  Neither 6 (15.4) 0 (0.0)
Systolic BP (mm Hg) 
  Median (IQR) 102 (91–114) 104 (89–115)
CRT (s) 
  Median (IQR) 3 (3–4) 3 (3–4)
PIM2r (2016) score (%) 
  Median (IQR) 2.1 (1.6–2.7) 2.0 (1.6–2.5)
Infection confirmed, n (%) 
  No 19 (48.7) 17 (50.0)
  Yes 20 (51.3) 17 (50.0)
Organism 
  Bacterial, n (%) 5 (31.3) 8 (50.0)
   Escherichia coli 1 (6.3) 4 (25.0)
   Enterococcus faecalis 2 (12.5) 0 (0.0)
   Group A streptococcus 1 (6.3) 1 (6.3)
   Group B streptococcus 0 (0.0) 1 (6.3)
   Staphylococcus aureus 1 (6.3) 0 (0.0)
   Meningococcus 0 (0.0) 1 (6.3)
   Gram-positive coccus (unspecified) 0 (0.0) 1 (6.3)
  Viral, n (%) 10 (62.5) 8 (50.0)
   Respiratory syncytial virus 5 (31.3) 3 (18.8)
   Rhinovirus 2 (12.5) 3 (18.8)
   Influenza A 0 (0.0) 1 (6.3)
   Metapneumovirus 1 (6.3) 0 (0.0)
   Enterovirus 1 (6.3) 1 (6.3)
   Rotavirus 1 (6.3) 0 (0.0)
  Others, n (%) 1 (6.3) 0 (0.0)
   Falciparum malaria 1 (6.3) 0 (0.0)
*CRT≥3 s.
BP, blood pressure; CRT, capillary refill time; PIM2r, Paediatric Index of Mortality, 
recalibrated version. 
Table 2 Protocol deviations by treatment group
Variables
10 ml/kg
(n=39)
20 ml/kg
(n=34)
Did not receive first bolus Patients, n (%) 3 (7.7) 0 (0.0)
Of subsequent boluses
Bolus given, shock criteria not met Deviations, n 0 1
Patients, n (%) 0 (0.0) 1 (2.9)
Shock criteria met, no bolus given Deviations, n 3 2
Patients, n (%) 3 (7.7) 2 (5.9)
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DIsCussIOn
The pilot trial was successfully conducted. Screening logs showed 
that over 90% of eligible patients were randomised across the 
study sites over the study period with a recruitment rate of 0.9 
participants per site per month, very close to the anticipated 
recruitment rate of 1 per site per month.
However, the sites opened over a 4-month period rather than 
all at once, reducing the anticipated recruitment total from 108 
to 84. Recruitment was driven mainly by three study sites, which 
recruited 38 of the 75 participants. A staggered opening of sites 
would be needed in the design for a larger FiSh trial, targeting 
sites most likely to see a high number of eligible patients.
The process of RWPC worked smoothly, with no parents 
refusing consent. This is likely due to the bespoke FiSh RWPC 
methodology, developed during the feasibility study.15 No partic-
ipants died during the course of the study, so the procedures to 
follow in the event of a child’s death were not tested.
The intervention was delivered according to protocol in the 
majority of participants. Adherence to volume and timing was 
close to achieving the 80% progression criteria target in the 
10 mL/kg group but was not as good in the 20 mL/kg group. 
This appeared to be due to the difficulty in delivering the 
20 mL/kg bolus within the 15 min time frame, especially in the 
period immediately postrandomisation. There was also some 
suggestions from the embedded perspectives study, indicating 
that some clinicians lacked equipoise, favouring 10 mL/kg over 
20 mL/kg fluid boluses, despite the recently updated ACCM-
PALS guidance continuing to recommend 20 mL/kg boluses.30 
Despite these challenges, good separation between the groups 
was achieved, with volume of fluid delivered (in mL/kg) 35% 
lower in the first hour and 44% lower over the entire 4-hour 
period in the 10 mL/kg group. If a larger trial were feasible, the 
resuscitation algorithm could be modified to improve adherence 
by allowing for longer periods to deliver study boluses.
Though the trial processes were deemed feasible, the popula-
tion had lower severity of illness than expected from previous data 
9 , impacting on the feasibility of a larger study. This may be a 
consequence of the inclusion criteria being too lax in the context 
of an increasingly immunised population. A recent Europe-wide 
study demonstrated that the disease burden of severe childhood 
infection is mainly in children younger than 5 years and is largely 
due to vaccine-preventable meningococcal and pneumococcal 
infections.31 However, in the UK, the childhood vaccination 
programme has resulted in massive reductions in the incidence of 
both group B meningococcal disease32 and invasive pneumococcal 
disease.33 Indeed, only one patient recruited into the FiSh pilot trial 
had a vaccine-preventable infection. Thus, if the FiSh inclusion 
criteria were to be changed to restrict to more severely ill children, 
then the number of eligible children would inevitably be reduced, 
Table 3 Treatment delivery by group
Variables 10 ml/kg 20 ml/kg
Patients, n 39 34
Number of study boluses delivered, n (%) of patients 
  0 3 (7.7) 0 (0.0)
  1 23 (59.0) 25 (73.5)
  2 8 (20.5) 6 (17.6)
  3 3 (7.7) 1 (2.9)
  4 or more 2 (5.1) 2 (5.9)
Total volume of study fluid received during the first hour (mL/kg)* 
  Mean (SD) 13.5 (8.0) 20.7 (8.3)
Total volume of study fluid received during the intervention period (mL/kg)* 
  Mean (SD) 14.5 (11.1) 25.7 (12.0)*
Total number of boluses delivered† 58 48
Volume of study bolus, n (%) of boluses 
  <10 mL/kg‡ 2 (3.4) 3 (6.3)
  10 mL/kg† 56 (96.6) 5 (10.4)
  20 mL/kg† 0 (0.0) 40 (83.3)
Timing of delivery of study bolus, n (%) of boluses§
  ≤15 min 38 (80.9) 30 (68.2)
  16–20 min 7 (14.9) 5 (11.4)
  21–30 min 2 (4.3) 1 (2.3)
  >30 min 0 (0.0) 8 (18.2)
Delivery of study bolus with 15 min by age group, n (%) of boluses‡
  <1 year 24/27 (88.9) 22/29 (75.9)
  1 to <2 years 7/9 (77.8) 2/3 (66.7)
  2 to <5 years 6/7 (85.7) 2/4 (50.0)
  ≥5 years 1/4 (25.0) 4/8 (50.0)
Study fluid boluses delivered at the correct volume and within 15 min, n (%) of 
boluses‡
  No 10 (21.3) 20 (45.5)
  Yes 37 (78.7) 24 (54.5)
*P<0.001 (t-test).
†All study boluses were of normal saline except 4 of plasmalyte and 4 of 
Hartmann’s solution.
‡±10%.
§Timing of delivery not reported for 15 boluses (11 in 10 mL/kg group, 4 in 20 mL/
kg group).
Table 4 Potential outcome measures by treatment group
Potential outcome measures
10 ml/kg
(n=39)
20 ml/kg
(n=34)
Difference
(95% CI)
Hospital mortality, n/N (%) 0/39 (0.0) 0/34 (0.0) NA
Length of hospital stay (days), median (IQR) (N) 4 (3–7) (39) 5 (4–8) (34) −1 (−2.5 to 0.5)
Transferred to PICU, n/N (%) 10/39 (25.6) 11/34 (32.4) −6.7 (−27.6 to 14.1)
Length of stay in PICU (hours), median (IQR) (N) 45 (18–143) (10) 119 (52–228) (11) −65 (−171 to 41)
Days alive and free of PICU up to 30 days postrandomisation, mean (SD) (N) 28.9 (2.4) (39) 27.9 (3.6) (34) 1.0 (−0.4 to 2.4)
Receipt of mechanical ventilation, n/N* (%) 4/36 (11.1) 8/32 (25.0) −13.9 (−32.1 to 4.3)
Duration of mechanical ventilation (days), median (IQR) (N)* 6 (4–8) (4) 5.5 (4–8.5) (8) 0 (−5.9 to 5.9)
Days alive and free of mechanical ventilation up to 30 days postrandomisation, mean (SD) (N)* 29.3 (2.1) (36) 28.5 (2.7) (32) 0.8 (−0.4 to 2.0)
Receipt of inotropes, n/N* (%) 1/36 (2.8) 5/32 (15.6) −12.8 (−26.5 to 0.8)
Mortality at 30 days postrandomisation, n/N (%) 0/39 (0.0) 0/34 (0.0) NA
*Organ support data missing for three patients in the 10 mL/kg group and two patients in the 20 mL/kg group transferred to PICUs not participating in the pilot trial.
NA, not available; PICU, paediatric intensive care unit. 
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impacting on the likelihood of completing a large-scale trial in an 
acceptable time frame in the UK.
A recent systematic review34 identified only one RCT, other 
than FEAST, which investigated different-sized fluid bolus 
therapy in children in septic shock.35 However, this was a small, 
single-centre study in India. Thus, at the time of writing, the 
optimum strategy for fluid bolus resuscitation in children with 
septic shock in high-income countries remains unknown.
COnClusIOns
A larger FiSh trial, with the current design, and in the UK, is not 
feasible. Further observational research is required to determine 
the epidemiology of severe childhood infection in the UK in the 
postvaccine era.
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